Jørgensen SF, Macpherson ME, Bjørnetrø T, Holm K, Kummen M, Rashidi A, Michelsen AE, Lekva T, Halvorsen B, Trøseid M, Mollnes TE, Berge RK, Yndestad A, Ueland T, Karlsen TH, Aukrust P, Hov JR, Fevang B (2019)
Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency
Sci Rep, 9 (1), 167
DOI 10.1038/s41598-018-35367-7, PubMed 30655568

Skulberg AK, Åsberg A, Khiabani HZ, Røstad H, Tylleskar I, Dale O (2019)
Pharmacokinetics of a novel, approved, 1.4 mg intranasal naloxone formulation for reversal of opioid overdose- a randomised controlled trial
Addiction (in press)
DOI 10.1111/add.14552, PubMed 30644628

Bekkelund M, Sangnes DA, Gunnar Hatlebakk J, Aabakken L (2019)
Pathophysiology of idiopathic gastroparesis and implications for therapy
Scand J Gastroenterol, 1-10 (in press)
DOI 10.1080/00365521.2018.1558280, PubMed 30638082